id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-N-0284-0009,FDA,FDA-2012-N-0284,FDA CDER Memorandum December 17 2013 re for use of Sodium Nitroprusside to Reduce Blood Pressure  in Pediatric Patients,Other,Memorandum,2013-12-24T05:00:00Z,2013,12,2013-12-24T05:00:00Z,,2013-12-24T13:59:09Z,,0,0,09000064814d51b8
FDA-2012-N-0284-0008,FDA,FDA-2012-N-0284,National Institutes of Health NIH National Institute of Child Health and Human Development NICHD Amendment,Other,Amendment,2013-09-26T04:00:00Z,2013,9,2013-09-26T04:00:00Z,,2013-09-26T22:02:42Z,,0,0,090000648143c837